Filed: 2/13/2026ACC: 0001999371-26-003325
π What this filing means
TPG GP A, LLC filed this quarterly 13FβHR report disclosing 10 equity positions with a total reported market value of $2.69B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$2.69B
Total AUM (reported)
245.13M
Total Shares
Allocation by class
COM$1.59B59.4%
COMMON STOCK$473.94M17.6%
COM SHS CL A$462.52M17.2%
COM STK CL A$155.34M5.8%
Portfolio Concentration
Top 3$2.07B77.0%
4β10$618.83M23.0%
Top 3 weight
77.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 245.13M
Sole
Full voting authority
245.13M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other10
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings10
Rows:
LifeStance Health Group Inc
DFNDShares160.71M
TypeSH
Market value$1.13B
42.11%
Sole
160.71M
Shared
0.00
None
0.00
Life Time Group Holdings Inc
DFNDShares17.83M
TypeSH
Market value$473.94M
17.64%
Sole
17.83M
Shared
0.00
None
0.00
BETA Technologies Inc
DFNDShares16.40M
TypeSH
Market value$462.52M
17.22%
Sole
16.40M
Shared
0.00
None
0.00
Sionna Therapeutics Inc
DFNDShares6.74M
TypeSH
Market value$277.49M
10.33%
Sole
6.74M
Shared
0.00
None
0.00
Amneal Pharmaceuticals Inc
DFNDShares12.33M
TypeSH
Market value$155.34M
5.78%
Sole
12.33M
Shared
0.00
None
0.00
CeriBell Inc.
DFNDShares3.97M
TypeSH
Market value$87.01M
3.24%
Sole
3.97M
Shared
0.00
None
0.00
Bicara Therapeutics Inc.
DFNDShares3.01M
TypeSH
Market value$50.67M
1.89%
Sole
3.01M
Shared
0.00
None
0.00
Allogene Therapeutics Inc
DFNDShares18.72M
TypeSH
Market value$25.64M
0.95%
Sole
18.72M
Shared
0.00
None
0.00
TPG RE Fin Tr Inc
DFNDShares2.39M
TypeSH
Market value$20.60M
0.77%
Sole
2.39M
Shared
0.00
None
0.00
Rallybio Corp
DFNDShares3.03M
TypeSH
Market value$2.09M
0.08%
Sole
3.03M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LifeStance Health Group IncDFND | Com | 160.71M | SH | $1.13B 42.11% | 160.71M | 0.00 | 0.00 |
Life Time Group Holdings IncDFND | Common Stock | 17.83M | SH | $473.94M 17.64% | 17.83M | 0.00 | 0.00 |
BETA Technologies IncDFND | Com Shs Cl A | 16.40M | SH | $462.52M 17.22% | 16.40M | 0.00 | 0.00 |
Sionna Therapeutics IncDFND | Com | 6.74M | SH | $277.49M 10.33% | 6.74M | 0.00 | 0.00 |
Amneal Pharmaceuticals IncDFND | Com Stk Cl A | 12.33M | SH | $155.34M 5.78% | 12.33M | 0.00 | 0.00 |
CeriBell Inc.DFND | Com | 3.97M | SH | $87.01M 3.24% | 3.97M | 0.00 | 0.00 |
Bicara Therapeutics Inc.DFND | Com | 3.01M | SH | $50.67M 1.89% | 3.01M | 0.00 | 0.00 |
Allogene Therapeutics IncDFND | Com | 18.72M | SH | $25.64M 0.95% | 18.72M | 0.00 | 0.00 |
TPG RE Fin Tr IncDFND | Com | 2.39M | SH | $20.60M 0.77% | 2.39M | 0.00 | 0.00 |
Rallybio CorpDFND | Com | 3.03M | SH | $2.09M 0.08% | 3.03M | 0.00 | 0.00 |